ARVO: Genetic link ID'd for strabismus and schizophrenia

May 5, 2015

ARVO: genetic link ID'd for strabismus and schizophrenia
(HealthDay)—There is a genetic link for strabismus and schizophrenia, with almost half of the genes dysregulated in strabismic medial rectus muscle identified as biomarkers for schizophrenia, according to a study presented at the annual meeting of the Association for Research in Vision and Ophthalmology, held from May 3 to 7 in Denver.

Austin J. Christensen, from the University of Nevada School of Medicine in Reno, and colleagues examined the correlation between schizophrenia and strabismus. The authors compared samples of strabismic lateral and medial rectus muscle, obtained during corrective surgeries, and normal samples from deceased organ donors. From paired comparisons (four per condition), they examined consistent differences of two-fold or more on targeted or customized arrays. Gene expression was assessed in 84 of interest based on known risk factors for schizophrenia.

The researchers found that 22 of the 381 genes encoding signaling molecules were dysregulated in strabismic medial rectus muscle versus normal rectus muscle. Ten of these genes were biomarkers for schizophrenia. Overall, 22.6 percent of the schizophrenia-related genes were differentially expressed in the medial rectus muscle, including cytokines, growth factors and their receptors, and downstream signaling pathways.

"Our data establish a molecular link between exotropia and ," the authors write. "This suggests that a combination of defects in signaling molecules is relevant in the pathogenesis of both diseases."

Explore further: An evolutionary approach reveals new clues toward understanding the roots of schizophrenia

More information: Press Release
More Information

Related Stories

An evolutionary approach reveals new clues toward understanding the roots of schizophrenia

February 24, 2015
Is mental illness simply the evolutionary toll humans have to pay in return for our unique and superior cognitive abilities when compared to all other species? But if so, why have often debilitating illnesses like schizophrenia ...

Schizophrenia and cannabis use may share common genes

June 24, 2014
Genes that increase the risk of developing schizophrenia may also increase the likelihood of using cannabis, according to a new study led by King's College London, published today in Molecular Psychiatry.

New technique helps determine degree of muscle wasting in critically ill patients

September 2, 2012
Researchers have identified a new technique that can help determine the severity of muscle loss in critically ill patients. The breakthrough could lead to new research to help prevent muscle-wasting and new therapeutic interventions ...

Experts find epigenetic changes moderate reality distortion in schizophrenia patients

June 10, 2013
A study in Schizophrenia Bulletin is among the first to indicate epigenetic changes related to immune function in schizophrenia. DNA methylation, a process involving the addition of a methyl group to the DNA without changing ...

Aligning the eyes: A simpler surgery for a complex condition

February 13, 2012
People with strabismus (misalignment and limited movement of one or more eyes) are often teased about their crossed-eye appearance; those with more complex, disfiguring strabismus can become socially isolated and develop ...

Researchers identify over 100 locations on the human genome associated with schizophrenia risk

March 4, 2015
An international consortium has combined data from 150,000 people around the globe to shed light on genetic risk factors for schizophrenia, a debilitating psychotic disorder.

Recommended for you

Researchers uncover molecular mechanisms linked to autism and schizophrenia

December 13, 2018
Since the completion of the groundbreaking Human Genome Project in 2003, researchers have discovered changes to hundreds of places in the DNA, called genetic variants, associated with psychiatric diseases such as autism spectrum ...

CRISPR joins battle of the bulge, fights obesity without edits to genome

December 13, 2018
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA. In a paper published Dec. 13, 2018, in the journal Science, UC San Francisco researchers describe how a modified version of CRISPR was used ...

Noncoding mutations contribute to autism risk

December 13, 2018
A whole-genome sequencing study of nearly 2,000 families has implicated mutations in 'promoter regions' of the genome—regions that precede the start of a gene—in autism. The study, which appears in the December 14 issue ...

New method for studying ALS more effectively

December 13, 2018
The neurodegenerative disease ALS causes motor neuron death and paralysis. However, long before the cells die, they lose contact with muscles as their axons atrophy. Researchers at Karolinska Institutet in Sweden have now ...

Paternal grandfather's high access to food may indicate higher mortality risk in grandsons

December 12, 2018
A paternal grandfather's access to food during his childhood is associated with mortality risk, especially cancer mortality, in his grandson, shows a large three-generational study from Stockholm University. The reason might ...

New genetic study could lead to better treatment of severe asthma

December 12, 2018
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.